ArticleTheranostics2022

CRISPR/Cas9-based genome-wide screening for deubiquitinase subfamily identifies USP1 regulating MAST1-driven cisplatin-resistance in cancer cells.

Apoorvi Tyagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.